Who owns C4 THERAPEUTICS INC?
- Ticker: CCCC
- CUSIP Number: 12529r107
Tip: Access positions for across all investors
Analyze quarterly positions in C4 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of C4 Therapeutics stock
Who bought or sold C4 THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 4.9M | $28M | 100% | Dec 2023 |
|
| Daniel D. Thurber | 4.3M | $35M | -39% | Mar 2024 |
|
| Commodore Capital | 3.8M | $22M | 100% | Dec 2023 |
|
| Lynx1 Capital Management | 3.1M | $18M | 208% | Dec 2023 |
|
| T. Rowe Price Associates | 2.6M | $15M | 17% | Dec 2023 |
|
| Arrowpoint Asset Management | 2.1M | $12M | -10% | Dec 2023 |
|
| Vanguard Group | 2.0M | $11M | 4% | Dec 2023 |
|
| Point72 Asset Management | 2.0M | $11M | 12142% | Dec 2023 |
|
| Soleus Capital Management | 1.8M | $10M | -32% | Dec 2023 |
|
| Balyasny Asset Management | 1.7M | $9.6M | 100% | Dec 2023 |
|
| Bank of America Corporation | 1.7M | $9.5M | 3594% | Dec 2023 |
|
| Marshall Wace | 1.1M | $6.3M | 100% | Dec 2023 |
|
| Millennium Management | 757k | $4.3M | -35% | Dec 2023 |
|
| Citadel Advisors | 353k | $2.0M | -16% | Dec 2023 |
|
| Cubist Systematic Strategies | 311k | $1.8M | 357% | Dec 2023 |
|
| UBS Group | 278k | $1.6M | -13% | Dec 2023 |
|
| Charles Schwab Investment Management | 253k | $1.4M | 2% | Dec 2023 |
|
| D. E. Shaw & Co | 244k | $1.4M | -44% | Dec 2023 |
|
| Jane Street | 199k | $1.1M | 100% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 168k | $950k | 2% | Dec 2023 |
|
| Man Group | 160k | $903k | 6% | Dec 2023 |
|
| AQR Capital Management | 149k | $840k | -86% | Dec 2023 |
|
| M^T Bank Corporation | 139k | $783k | -1% | Dec 2023 |
|
| Citigroup | 136k | $765k | 134% | Dec 2023 |
|
| Mariner Wealth Advisors | 128k | $723k | 1% | Dec 2023 |
|
| Dimensional Fund Advisors | 116k | $653k | -37% | Dec 2023 |
|
| Goldman Sachs Group | 114k | $641k | -48% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 102k | $578k | 100% | Dec 2023 |
|
| Jacobs Levy Equity Management | 100k | $567k | -88% | Dec 2023 |
|
| Simplex Trading | 95k | $536k | 100% | Dec 2023 |
|
| TD Asset Management | 94k | $533k | 100% | Dec 2023 |
|
| Bank Of Montreal | 77k | $463k | 100% | Dec 2023 |
|
| Harbor Capital Advisors | 76k | $428k | 7% | Dec 2023 |
|
| Two Sigma Advisers | 73k | $411k | -90% | Dec 2023 |
|
| Arete Wealth Advisors | 72k | $407k | 100% | Dec 2023 |
|
| Bellevue Group | 62k | $350k | 100% | Dec 2023 |
|
| 683 Capital Management | 56k | $314k | 100% | Dec 2023 |
|
| CornerCap Investment Counsel | 46k | $262k | -2% | Dec 2023 |
|
| Squarepoint Ops | 46k | $260k | 100% | Dec 2023 |
|
| Barclays | 44k | $247k | 0% | Dec 2023 |
|
| Royce & Associates | 43k | $240k | 100% | Dec 2023 |
|
| Hsbc Holdings | 30k | $171k | -8% | Dec 2023 |
|
| Algert Coldiron Investors | 28k | $158k | -46% | Dec 2023 |
|
| Bank of New York Mellon | 21k | $117k | -1% | Dec 2023 |
|
| Mirabella Financial Services | 18k | $104k | 100% | Dec 2023 |
|
| Commonwealth Equity Services | 16k | $92k | 5% | Dec 2023 |
|
| Captrust Financial Advisors | 15k | $84k | 0% | Dec 2023 |
|
| Principal Financial Group | 15k | $83k | 6% | Dec 2023 |
|
| CI Private Wealth | 13k | $72k | 0% | Dec 2023 |
|
| Lazard Asset Management | 12k | $69k | 100% | Dec 2023 |
|
| Sherbrooke Park Advisers | 11k | $63k | 100% | Dec 2023 |
|
| Shay Capital | 10k | $57k | 100% | Dec 2023 |
|
| FNY Investment Advisers | 8.8k | $49k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 6.9k | $39k | -25% | Dec 2023 |
|
| Headlands Technologies | 6.9k | $39k | 100% | Dec 2023 |
|
| Point72 Asia | 3.9k | $22k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 1.8k | $10k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 1.3k | $7.4k | 290% | Dec 2023 |
|
| Syntax Research | 1.0k | $5.7k | 100% | Dec 2023 |
|
| Cutler | 800.00 | $6.0k | -95% | Mar 2024 |
|
| Piscataqua Savings Bank | 600.00 | $4.9k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 543.00 | $3.0k | -91% | Dec 2023 |
|
| Efficient Wealth Management | 331.00 | $2.0k | 100% | Dec 2023 |
|
| Coston, McIsaac & Partners | 23.00 | $0 | 21% | Mar 2024 |
|
Who sold out of C4 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aquilo Capital Management | Sep 2023 | 2.0M | $3.7M |
| Nantahala Capital Management | Sep 2023 | 1.0M | $1.9M |
| Two Sigma Investments | Sep 2023 | 403k | $749k |
| Nextech Invest | Sep 2023 | 376k | $699k |
| Raymond James & Associates | Dec 2023 | 101k | $571k |
| Russell Investments | Sep 2023 | 96k | $178k |
| Ohio Pers | Sep 2023 | 71k | $132k |
| State of Wisconsin Investment Board | Sep 2023 | 30k | $56k |
| Tudor Investment Corporation | Sep 2023 | 15k | $28k |
| SG Americas Securities | Sep 2023 | 12k | $22k |
| Federated Investors | Sep 2023 | 3.1k | $5.8k |
| China Universal Asset Management | Sep 2023 | 1.3k | $2.0k |
| Advisor Group Holdings | Sep 2023 | 1.0k | $1.9k |
| NISA Investment Advisors | Sep 2023 | 490.00 | $911.008000 |
| EverSource Wealth Advisors | Sep 2023 | 448.00 | $833.011200 |
| Daiwa Securities Group | Sep 2023 | 142.00 | $0 |